clinical trials

July 18, 2017July 18, 2017

Bayer’s Ciprofloxacin DPI Shows Promise in Treating Non-cystic Fibrosis Bronchiectasis

News

Bayer is conducting two Phase 3 clinical trials evaluating ciprofloxacin Dry Powder for Inhalation (ciprofloxacin DPI) as a treatment for non-cystic fibrosis (non-CF) bronchiectasis, and preliminary data show promising results. The ... Read more

June 13, 2017June 13, 2017

Lipitor May Help Bronchiectasis Patients Infected with P. aeruginosa, Study Finds

News

Long-term use of statins can benefit bronchiectasis patients with chronic Pseudomonas aeruginosa pulmonary infection by improving their systemic inflammatory status and their quality of life, according to a study published recently ... Read more

May 23, 2017May 23, 2017

Lung Disease Patients Benefit from Using a Home Ventilator, Study Finds

News

Patients with lung diseases such as chronic obstructive pulmonary disease (COPD) and bronchiectasis may live better lives when treated with a noninvasive ventilation (NIV) system at home, according to the ... Read more